Dr. Neil Morganstein, MD

Media Releases

Get to know Hematologist-Oncologist Dr. Neil Morganstein, who serves patients throughout the State of New Jersey.

A skilled hematologist-oncologist, Dr. Morganstein is the Director of the Leukemia/Lymphoma Panel at Medical Diagnostic Associates, PA, working with patients at their offices in Summit and Union, New Jersey. He also serves as the Assistant Medical Director of the Cancer Center at Overlook Medical Center.

Medical Diagnostic Associates, PA is a multi-specialty group of doctors located in North Jersey & Central New Jersey. Their founding physicians built a caring network of doctors that provides superior service, and compassionate and comprehensive medical care to all their patients.

Completing his undergraduate education at Rutgers College, Dr. Morganstein earned his medical degree from the Thomas Jefferson Medical College. He completed his residency in internal medicine at the Robert Wood Johnson University Hospital of New Brunswick, where he served as Chief Resident. Finally, he completed his fellowship in hematology/oncology at the same educational venue.

As a testament of his continued education, the doctor is board-certified in hematology, medical oncology, and internal medicine by the American Board of Internal Medicine. The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

In order to remain up to date in his field, Dr. Morganstein maintains membership in many distinguished organizations, including the American Society of Clinical Oncologists and the American Society of Hematologists.

With his many speaking engagements and commitment to education, he has a reputation as a leader in the treatment of hematological and oncological issues. He is a national speaker in the area of multiple myeloma, as well as co-chair of a video conference on the management of patients with multiple myeloma. 

With a special interest in lung cancer and multiple myeloma, Dr. Morganstein has published and presented several peer-reviewed articles, posters and abstracts at regional and national oncology meetings. These have focused on multiple myeloma, lymphoma, prostate cancer, gastric cancer, and hematological complications during pregnancy.

As an involved and committed oncologist, he gives several lectures a year educating medical students. He teaches the hematology board review course for the American College of Physicians, as well as the hematology and oncology course for residents at Rutgers University. In addition, he thoroughly enjoys working with medical students in the hospital.

Hematology is the branch of medicine concerned with the study of the cause, prognosis, treatment, and prevention of diseases related to blood. Oncology is a branch of medicine that deals with the prevention, diagnosis, and treatment of cancer. A hematologist-oncologist is a physician who specializes in the diagnosis, treatment, or prevention of cancer, malignant blood diseases such as leukemia, lymphoma, and multiple myeloma, and blood disorders such as iron-deficiency anemia, clotting abnormalities, hemophilia, and sickle-cell disease.

Among his most notable achievements, Dr. Morganstein has been the recipient of the Patients’ Choice Award (2018, 2017, 2012, 2011, 2010, 2009, 2008), Compassionate Doctor Recognition (2018, 2017, 2012, 2010), On-Time Doctor Award (2018, 2017), and Patients’ Choice 5th Anniversary Award (2012).

Recommended Articles

• The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer

  On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...

• Treatment Options of Multiple Myeloma

  A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...

• Tips on How to Live with Multiple Myeloma

  Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...

• Promising Results for Hodgkin Patients Using This Therapy

  Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...

• How This Survivor Star Beat Hodgkin Lymphoma—Twice

  Ethan Zohn is a survivor in many ways. In 2002, he outlasted 15 fiercely strong competitors on the popular TV show, Survivor: Africa. His strength, wit, athleticism, and perseverance won him a million-dollar prize after he defeated these opponents. However, his victory was short-lived. Little did he...

• Potential Causes of Leukopenia

  IntroductionA decrease in the number of white blood cells (WBCs) is referred to as leukopenia. There are several causes for leukopenia. It may be due to certain drugs, cancer, radiation and chemotherapy for cancer, stem cell transplant, surgery, steroids, or autoimmune disorders. The immune system...